Deborah Sellmeyer Lab

  • Research in the Deborah Sellmeyer Lab focuses on osteoporosis, nutrition, and all metabolic bone disorders. As part of an American Society for Bone and Mineral Research task force, we provided guidance on bisphosphonates (BP) therapy duration with a risk benefit perspective. Another recent study determined that thiazolidinediones (TZD) use was associated with increased non-spine fractures in women, but not men, with type 2 diabetes.

    Research Areas: osteoporosis, nutrition, metabolic bone disorders, endocrinology

    Principal Investigator

    Deborah Sellmeyer, M.D.